EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-24
SponsorEUthyroid

About this trial

In EUthyroid2 intervention measures are to be developed, implemented in ambulatory care settings and evaluated to effectively raise awareness for the risks of iodine deficiency among young women (18-24 years) in three European countries (Norway, Poland, UK) as well as Bangladesh and Pakistan. A cluster-randomized controlled trial with three points of measurements will be applied in each participating country. The intervention will be adapted to the different contextual characteristics of the implementation sites. A process evaluation with a convergent parallel mixed methods design will be conducted. For this, participants and healthcare professionals will be surveyed and semi-structured interviews will be carried out.

Eligibility criteria

Qualifiers

non-pregnant Female

Age 18-24 years at the time point of recruitment

Attending the specified settings

Sufficient language skills to understand the study information, informed consent and the questionnaire

Disqualifiers

Having a thyroid disease

Pregnancy at the timepoint of recruitment and during the intervention period

Lactation

Trial design

Treatments tested in this trial

  • Educational intervention measures on iodine, iodine deficiency and iodine intake

Treatment groups

1,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

EUthyroid

Lead sponsor

EU Horizon

Collaborator

UK Research and Innovation

Collaborator